Dr Reddy's has released its quarterly results. The company's second quarter profit fell 9 percent to Rs 1342 crore compared to last year, while the income has increased by more than 16 percent during this period. EBITDA has increased by more than 3 percent during this period. The company's profit has been lower than the figures found in the CNBC TV 18 poll. At the same time, EBITDA and EBITDA margin have also been below estimates. The company has released its quarterly results after the market closed. The stock closed with a gain of about half a percent in Tuesday's trading.

How were the quarterly results?

The company's profit has come down from Rs 1482 crore to Rs 1342 crore compared to last year, that is, it has declined by 9.4 percent compared to last year. In CNBC TV18's poll, the profit was estimated to be Rs 1470 crore. In the second quarter, the income has increased from Rs 6880 crore to Rs 8016.2 crore, that is, the income has seen a growth of 16.5 percent on a year-on-year basis. EBITDA has increased by 3.4 percent compared to last year to Rs 2054 crore. Which was at the level of Rs 1985.8 crore a year ago. The market had estimated an EBITDA of Rs 2163.85 crore. During this period, the EBITDA margin decreased from 29 percent to 25.6 percent. The market had estimated a margin of 28 percent. How was the stock performance? Dr. Reddy's Lab stock closed at 1272 with a gain of 0.4 percent in Tuesday's trading. During the session, the stock reached the day's highest level of 1279.85. The stock's yearly high is 1420 and lowest level is 1058.